Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

491
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
491
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

4.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The rise of medical autonomous care, a paradigmatic turning point for military and civilian delivery of health care.

Journal of critical care·2026
Same author

Methodological approaches for estimating radiosensitivity in <i>Quillaja saponaria</i>: comparison of LD<sub>50</sub> models and a PCA-based integrative index.

International journal of radiation biology·2026
Same author

AI Diffusion Models Generate Realistic Synthetic Dental Radiographs Using a Limited Dataset.

Journal of imaging·2025
Same author

Experience with second allogeneic hematopoietic stem cell transplantation in Chilean patients: A single-center study.

Hematology, transfusion and cell therapy·2025
Same author

Field Testing of the Compensatory Reserve Measurement Monitoring Capability: Results From the 2024 Army Warfighter Expeditionary Experiment.

Military medicine·2025
Same author

Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study.

Cancer medicine·2025

相关实验视频

Updated: Sep 9, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

257

急性骨髓性白血病:一个全面的更新

Maria Jose Garcia-Rodriguez1, Yorman Flores1, Jose Salinas2

  • 1Hematopoietic Stem Cell Transplantation Program. Hematology Department Pontificia Universidad Católica de Chile Red de Salud Christus UC.

Current opinion in hematology
|September 5, 2025
PubMed
概括

最近急性骨髓性白血病 (AML) 的进展主要集中在基因改变上, 可测量的残留疾病 (MRD) 监测指导治疗,改善AML患者的治疗结果.

关键词:
急性骨髓性白血病同源干细胞移植针对性的治疗

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K

相关实验视频

Last Updated: Sep 9, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

257
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K

科学领域:

  • 血液学
  • 癌症学
  • 分子遗传学

背景情况:

  • 急性髓性白血病 (AML) 是一种复杂的血液恶性瘤,具有多种遗传基础.
  • 近年来,人们在了解AML的分子环境和开发新疗法方面取得了快速进展.

研究的目的:

  • 综合到2025年的AML诊断,分类和治疗方面的最新进展.
  • 为临床医生和研究人员提供关于管理AML的最新观点.

主要方法:

  • 对最近的文献和临床研究结果的回顾.
  • 对最新的世卫组织和ICC分类进行分析.
  • 关于分子分析和向治疗的综合数据.

主要成果:

  • 新的分类强调精确的AML亚型的遗传变化.
  • 分子分析增强了风险分层,并突出了可测量的残留疾病 (MRD) 的作用.
  • 针对性药物 (FLT3,IDH1/ 2,脑膜抑制剂) 为特定的患者群体提供了新的选择,包括那些不适合进行密集化疗或复发疾病的患者.

结论:

  • 基因组的洞察力和新疗法正在改变AML的治疗方式,
  • 不断发展的后缓解策略,包括MRD指导的决策和维持疗法,旨在改善长期疾病控制.
  • 像CAR-T细胞疗法这样的新兴治疗方法对未来的AML治疗有希望.